|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Operating expenses: | |||||
| Practice salaries and benefits | |||||
| Practice supplies and other operating expenses | |||||
| General and administrative expenses | |||||
| Gain on sale of building | |||||
| Depreciation and amortization | |||||
| Transformational and restructuring related expenses | |||||
| Goodwill impairment | |||||
| Long-lived asset impairments | |||||
| Loss on disposal of businesses | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Investment and other income | |||||
| Net gain on investments in divested businesses | |||||
| Interest expense | |||||
| Impairment of strategic investment | |||||
| Loss on early extinguishment of debt | |||||
| Equity in earnings of unconsolidated affiliate | |||||
| Total non-operating income (expenses) | |||||
| Income (loss) before income taxes | |||||
| Income tax (provision) benefit | |||||
| (Loss) income from continuing operations | |||||
| Income from discontinued operations, net of tax | |||||
| Net income (loss) | |||||
| Net loss attributable to noncontrolling interests | |||||
| Net (loss) income attributable to Pediatrix Medical Group, Inc. | |||||
| Unrealized holding gain on investments, net of tax of $526, $374 and $527 | |||||
| Total comprehensive income (loss) | |||||
| Basic | |||||
| Diluted | |||||
| Net income (loss): | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average common shares: | |||||
| Basic | |||||
| Diluted |
Loading...